Gilead to stop late-stage study of Covid-19 treatment
April 12, 2021 at 18:08 PM EDT
Gilead Sciences said on Monday it had decided to stop a late-stage trial of its intravenous treatment, Veklury, in high-risk non-hospitalized patients with Covid-19.
